Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.22.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Collaboration revenue $ 129,799
Operating expenses:    
Research and development 4,265,866 3,866,007
General and administrative 2,078,885 1,997,986
Total operating expenses 6,344,751 5,863,993
Loss from operations (6,214,952) (5,863,993)
Foreign exchange gain (loss) 13,971 (13,247)
Net loss $ (6,200,981) $ (5,877,240)
Per share information:    
Net loss per share, basic and diluted $ (0.10) $ (0.34)
Weighted average shares outstanding, basic and diluted 60,293,010 17,218,485